Uni-Bio Science Group Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Uni-Bio Science Group Limited with three other
companies in this sector in Hong Kong:
Ascletis Pharma Inc
sales of 61.57 million Hong Kong Dollars [US$7.84 million]
Tianda Pharmaceuticals Ltd
(195.54 million Hong Kong Dollars [US$24.91 million]
of which 100%
was Pharmaceutical and Biotechnology Busines), and
China Biotech Services Holdings Ltd
(105.14 million Hong Kong Dollars [US$13.39 million]
Uni-Bio Science Group Limited reported sales of HK$156.48 million (US$19.94 million)
December of 2017.
increase of 6.8%
versus 2016, when the company's sales were HK$146.49 million.
Sales at Uni-Bio Science Group Limited have increased during each of the previous five years
(and since 2012, sales have increased a total of 174%).
Sales of In-House Chemical Pharmaceutical Products saw an increase
that was more than double the company's growth rate: sales were up
14.4% in 2017, from
HK$60.49 million to HK$69.19 million.